前收市價 | 220.52 |
開市 | 220.54 |
買盤 | 216.79 x 800 |
賣出價 | 224.40 x 800 |
今日波幅 | 218.27 - 221.35 |
52 週波幅 | 200.32 - 263.13 |
成交量 | |
平均成交量 | 583,795 |
市值 | 19.558B |
Beta 值 (5 年,每月) | 1.04 |
市盈率 (最近 12 個月) | 19.82 |
每股盈利 (最近 12 個月) | 11.14 |
業績公佈日 | 2023年7月26日 - 2023年7月31日 |
遠期股息及收益率 | 2.88 (1.31%) |
除息日 | 2023年5月17日 |
1 年預測目標價 | 273.08 |
In this article, we take a look at 27 largest biotech companies in the US. You can skip our detailed analysis of the biotech industry and go directly to the 5 Largest Biotech Companies in the US. The largest biotech companies in the US have a total market cap of $88 trillion. Latest Developments in […]
While the concept of acquiring low-PE ratio blue-chip stocks (that is, industry-leading stalwarts that feature low price-earnings ratios relative to their sectors) appeals on paper, investors need to be cautious. You can’t just buy companies based on any one single metric. In addition, sometimes a very cheap PE can actually signal significant fundamental problems. Instead, investors will want to consider blue-chip stocks with value – and by that, I’m talking about substantive value. Rather than
In this article, we discuss companies that just started paying dividends. You can skip our detailed analysis of dividend stocks and their importance, and go directly to read 5 Companies that Just Started Paying Dividends. The pandemic of 2020 took a toll on dividend payments in the US stock market. Nearly 190 companies ceased their […]
Laboratory Corporation of America Holdings (NYSE:LH) Q4 2022 Earnings Call Transcript February 16, 2023 Operator: Good day and thank you for standing by. Welcome to the Q4 and Full Year 2022 Labcorp Conference Call. Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker […]
Laboratory Corp of America Holdings (NYSE: LH) posted Q3 revenues of $3.61 billion, a decrease of 11.2% Y/Y, missing the consensus of $3.79 billion. The 10.7% decrease in organic revenue was driven by an 11.8% decrease in COVID-19 Testing, partially offset by a 1.1% increase in the company's organic Base Business. "We continue to manage inflationary headwinds and labor constraints through our LaunchPad initiatives. And, we are accelerating the planned spin-off of our Clinical Development busines
Labcorp CEO Adam Schechter joined Yahoo Finance's All Markets Summit to discuss the growth opportunities in diagnostic testings and lessons learned during the COVID-19 pandemic.
In this article, we will look at the 10 best value stocks to buy for the next decade. If you want to skip reading about the comparison between the returns generated by value and growth stocks, go directly to 5 Best Value Stocks to Buy for the Next Decade. During the five years from 2017 […]
Laboratory Corp of America Holdings (NYSE: LH) plans to spin off its unit focused on the clinical development business. Wall Street Journal was the first to report the news. The clinical drug trial business operates as a Contract Research Organization, providing Phase I-IV clinical trial management, market access, and technology solutions to pharmaceutical and biotechnology organizations. According to WSJ, the move will create a new stand-alone company in the fast-growing contract-research secto
In this article we present the list of 8 Stocks Billionaire Barry Rosenstein Loves (And 2 He’s Given Up On). Click to skip ahead and see the 4 Stocks Billionaire Barry Rosenstein Loves (And 1 He’s Given Up On). Macy’s, Inc. (NYSE:M), Zendesk Inc (NYSE:ZEN), and Conagra Brands, Inc. (NYSE:CAG) were a few of the most […]